These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

424 related articles for article (PubMed ID: 28371273)

  • 1. FEN1 promotes tumor progression and confers cisplatin resistance in non-small-cell lung cancer.
    He L; Luo L; Zhu H; Yang H; Zhang Y; Wu H; Sun H; Jiang F; Kathera CS; Liu L; Zhuang Z; Chen H; Pan F; Hu Z; Zhang J; Guo Z
    Mol Oncol; 2017 Jun; 11(6):640-654. PubMed ID: 28371273
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeting DNA Flap Endonuclease 1 to Impede Breast Cancer Progression.
    He L; Zhang Y; Sun H; Jiang F; Yang H; Wu H; Zhou T; Hu S; Kathera CS; Wang X; Chen H; Li H; Shen B; Zhu Y; Guo Z
    EBioMedicine; 2016 Dec; 14():32-43. PubMed ID: 27852524
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Overexpression of Flap Endonuclease 1 Correlates with Enhanced Proliferation and Poor Prognosis of Non-Small-Cell Lung Cancer.
    Zhang K; Keymeulen S; Nelson R; Tong TR; Yuan YC; Yun X; Liu Z; Lopez J; Raz DJ; Kim JY
    Am J Pathol; 2018 Jan; 188(1):242-251. PubMed ID: 29037854
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PRMT1 is critical to FEN1 expression and drug resistance in lung cancer cells.
    He L; Hu Z; Sun Y; Zhang M; Zhu H; Jiang L; Zhang Q; Mu D; Zhang J; Gu L; Yang Y; Pan FY; Jia S; Guo Z
    DNA Repair (Amst); 2020 Nov; 95():102953. PubMed ID: 32861926
    [TBL] [Abstract][Full Text] [Related]  

  • 5. FEN1 is overexpressed in testis, lung and brain tumors.
    Nikolova T; Christmann M; Kaina B
    Anticancer Res; 2009 Jul; 29(7):2453-9. PubMed ID: 19596913
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Small molecule inhibitors uncover synthetic genetic interactions of human flap endonuclease 1 (FEN1) with DNA damage response genes.
    Ward TA; McHugh PJ; Durant ST
    PLoS One; 2017; 12(6):e0179278. PubMed ID: 28628639
    [TBL] [Abstract][Full Text] [Related]  

  • 7. FEN1 endonuclease as a therapeutic target for human cancers with defects in homologous recombination.
    Guo E; Ishii Y; Mueller J; Srivatsan A; Gahman T; Putnam CD; Wang JYJ; Kolodner RD
    Proc Natl Acad Sci U S A; 2020 Aug; 117(32):19415-19424. PubMed ID: 32719125
    [TBL] [Abstract][Full Text] [Related]  

  • 8. EHD1 confers resistance to cisplatin in non-small cell lung cancer by regulating intracellular cisplatin concentrations.
    Gao J; Meng Q; Zhao Y; Chen X; Cai L
    BMC Cancer; 2016 Jul; 16():470. PubMed ID: 27411790
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Knockdown of REV3 synergizes with ATR inhibition to promote apoptosis induced by cisplatin in lung cancer cells.
    Jiang HG; Chen P; Su JY; Wu M; Qian H; Wang Y; Li J
    J Cell Physiol; 2017 Dec; 232(12):3433-3443. PubMed ID: 28075014
    [TBL] [Abstract][Full Text] [Related]  

  • 10. NDRG1 disruption alleviates cisplatin/sodium glycididazole-induced DNA damage response and apoptosis in ERCC1-defective lung cancer cells.
    He L; Liu K; Wang X; Chen H; Zhou J; Wu X; Liu T; Yang Y; Yang X; Cui D; Song G; Wang J; Lei J
    Int J Biochem Cell Biol; 2018 Jul; 100():54-60. PubMed ID: 29768183
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Letrozole improves the sensitivity of breast cancer cells overexpressing aromatase to cisplatin via down-regulation of FEN1.
    Wang Y; Li S; Zhu L; Zou J; Jiang X; Chen M; Chen B
    Clin Transl Oncol; 2019 Aug; 21(8):1026-1033. PubMed ID: 30712236
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Flap endonuclease 1 silencing is associated with increasing the cisplatin sensitivity of SGC‑7901 gastric cancer cells.
    Xie C; Wang K; Chen D
    Mol Med Rep; 2016 Jan; 13(1):386-92. PubMed ID: 26718738
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of FEN1 promotes DNA damage and enhances chemotherapeutic response in prostate cancer cells.
    Wang Z; Yong C; Fu Y; Sun Y; Guo Z; Liu SB; Hu Z
    Med Oncol; 2023 Jul; 40(8):242. PubMed ID: 37452976
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MicroRNA-140 impedes DNA repair by targeting FEN1 and enhances chemotherapeutic response in breast cancer.
    Lu X; Liu R; Wang M; Kumar AK; Pan F; He L; Hu Z; Guo Z
    Oncogene; 2020 Jan; 39(1):234-247. PubMed ID: 31471584
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Simultaneous targeting of ATM and Mcl-1 increases cisplatin sensitivity of cisplatin-resistant non-small cell lung cancer.
    Zhang F; Shen M; Yang L; Yang X; Tsai Y; Keng PC; Chen Y; Lee SO; Chen Y
    Cancer Biol Ther; 2017 Aug; 18(8):606-615. PubMed ID: 28686074
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chronic cisplatin treatment promotes enhanced damage repair and tumor progression in a mouse model of lung cancer.
    Oliver TG; Mercer KL; Sayles LC; Burke JR; Mendus D; Lovejoy KS; Cheng MH; Subramanian A; Mu D; Powers S; Crowley D; Bronson RT; Whittaker CA; Bhutkar A; Lippard SJ; Golub T; Thomale J; Jacks T; Sweet-Cordero EA
    Genes Dev; 2010 Apr; 24(8):837-52. PubMed ID: 20395368
    [TBL] [Abstract][Full Text] [Related]  

  • 17. YY1 suppresses FEN1 over-expression and drug resistance in breast cancer.
    Wang J; Zhou L; Li Z; Zhang T; Liu W; Liu Z; Yuan YC; Su F; Xu L; Wang Y; Zhou X; Xu H; Hua Y; Wang YJ; Zheng L; Teng YE; Shen B
    BMC Cancer; 2015 Feb; 15():50. PubMed ID: 25885449
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synergistic antitumor effect of combined paclitaxel with FEN1 inhibitor in cervical cancer cells.
    He L; Yang H; Zhou S; Zhu H; Mao H; Ma Z; Wu T; Kumar AK; Kathera C; Janardhan A; Pan F; Hu Z; Yang Y; Luo L; Guo Z
    DNA Repair (Amst); 2018 Mar; 63():1-9. PubMed ID: 29358095
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Flap endonuclease 1 is a promising candidate biomarker in gastric cancer and is involved in cell proliferation and apoptosis.
    Wang K; Xie C; Chen D
    Int J Mol Med; 2014 May; 33(5):1268-74. PubMed ID: 24590400
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Jianpi-yangwei decoction inhibits DNA damage repair in the drug resistance of gastric cancer by reducing FEN1 expression.
    Huang W; Tang H; Wen F; Lu X; Li Q; Shu P
    BMC Complement Med Ther; 2020 Jun; 20(1):196. PubMed ID: 32586310
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.